South Africa Launches Breakthrough HIV Prevention Injection Lenacapavir
South Africa launches Lenacapavir, a twice-yearly injectable HIV prevention drug, marking a major scientific breakthrough in the fight against the world’s largest epidemic.
News & Insights Across Asia
South Africa launches Lenacapavir, a twice-yearly injectable HIV prevention drug, marking a major scientific breakthrough in the fight against the world’s largest epidemic.
King’s College Hospital in London introduces a groundbreaking rooftop garden, allowing critical care patients to access nature while receiving full life support.